The JAVELIN Bladder 100 trial established avelumab (Bavencio) as a standard switch maintenance therapy, according to Grivas. It showed significant survival benefit for patients who achieve disease ...
India Today on MSN
MD course to start at IIT Kharagpur with 20 seats, MBBS put on hold
IIT Kharagpur is set to launch its first postgraduate MD (Doctor of Medicine) programme, pending approval from the National ...
8h
Chicago Bears Q&A: What impact will the return of T.J. Edwards and Kyler Gordon have on the defense?
With T.J. Edwards returning to health, will the Chicago Bears use more standard 4-3 fronts? Brad Biggs answers your Bears ...
Social determinants of health disproportionately impact patients' ability to maintain and achieve their weight loss goals.
Nurse practitioners and physician associates are increasingly involved in delivering care across specialties, especially ...
11hon MSN
Jayden Daniels and Caleb Williams match up again 1 year after Hail Mary decided Bears-Commanders
Jayden Daniels and Caleb Williams will face each other again as pros when the Washington Commanders host the Chicago Bears on ...
Medpage Today on MSN
Poor Heart Health in Youth Linked With Later Pregnancy Risks
Neither poor nor intermediate adolescent CV health carried increased risk for future hypertensive disorders of pregnancy (HDP ...
Fanatics now offers a Game Day Guarantee, which gives new users $100 FanCash and up to $100 back in FanCash every football ...
Emma Guttman, MD, PhD, discusses the promising potential of rocatinlimab in targeting the OX40-OX40 ligand pathway for atopic dermatitis treatment.
Seven UCSF investigators are receiving the prestigious award for their research from the National Institutes of Health.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback